Biotech Values

[lumpy9200]

ARAY

Ahh, so you're responsible for the sell-off earlier today.

:)

I haven't seen before where a company openly denies admission to a negative analyst, so I don't know about any precedent, but......might it not be as likely ARAY had something to hide as that they actually had good things to say, and felt like leaving the perpetually bearish analyst in the dark (perhaps to make him look bad when things go well and he still has a sell rating)? The Jefferies analyst seemingly took Ecstasy before writing his report with the $29 price target.

Either way, it seems childish on the part of management. I'm just not sure it implies that there is anything to hide.

Best regards,
Geoff